Allvest powered by Allianz erhält erneut Bestnote - bis 5. September bei Vertragsabschluss 15€ Bonus sichern!-w-

EVOTEC Aktie 

34,67EUR
-0,04EUR
-0,12%
16:45:08
Hier für 0 Euro handeln mit
mehr Daten anzeigen
Werbung

EVOTEC Aktien News

26.07.21
Evotec SE : Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (Investegate)
30.06.21
Evotec SE : Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (Investegate)
21.06.21
Evotec SE : Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (Investegate)
15.06.21
Evotec SE : Evotec SE virtual Annual General Meeting 2021 approves all proposed agenda items (Investegate)
15.06.21
Evotec SE : Evotec launches 'PRROTECT', a pre-competitive initiative to be better prepared for future pandemics (Investegate)
25.05.21
Evotec SE : Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (Investegate)
11.05.21
Evotec SE : EVOTEC SE REPORTS RESULTS FOR THE FIRST QUARTER 2021 AND PROVIDES CORPORATE UPDATE (Investegate)
30.04.21
Evotec SE : Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (Investegate)
27.04.21
Awakn Life Sciences Initiates New Chemical Entity Development Program with Evotec as Research Partner and Addiction Expert, Prof. David Nutt, as Program Lead (Newsfile)
23.04.21
Evotec SE : Chairman of the Supervisory Board of Evotec to resign from office effective as of the end of the Annual General Meeting on 15 June 2021 (Investegate)
20.04.21
Evotec SE : Evotec accelerates access to biologic therapeutics with initiation of manufacturing facility in Toulouse (Investegate)
19.04.21
Evotec SE : Evotec enters partnership with Kazia Therapeutics for clinical development of EVT801 (Investegate)
13.04.21
Evotec SE : Evotec launches 'beLAB2122', translating academic innovation from leading German life science region in collaboration with Bristol Myers Squibb (Investegate)
09.04.21
Evotec SE : Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (Investegate)
09.04.21
Evotec SE : Evotec and Exscientia announce start of human clinical trials of novel immuno-oncology drug (Investegate)
31.03.21
Evotec SE : Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (Investegate)
25.03.21
Evotec SE : EVOTEC SE FISCAL YEAR 2020 RESULTS: GAINING SPEED ON 'THE DATA-DRIVEN R&D AUTOBAHN TO CURES' (Investegate)
18.03.21
Evotec SE : Evotec SE to announce results for fiscal year 2020 on 25 March 2021 (Investegate)
26.02.21
Evotec SE : Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (Investegate)
09.02.21
Evotec SE : Evotec and Related Sciences enter integrated drug discovery and development partnership (Investegate)
04.02.21
Evotec SE : Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (Investegate)
04.02.21
Evotec SE : Evotec and Medical Center Hamburg-Eppendorf Enter Partnership to Develop iPSC-Based Tissue Therapy for Heart Failure (Investegate)
29.01.21
Evotec SE : Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (Investegate)
28.01.21
Evotec SE : Evotec Starts Clinical Development of Chikungunya Antibody together with NIAID and Leading Academic Research Organisation (Investegate)
27.01.21
Evotec SE : Just - Evotec Biologics Expands Contract with the Department of Defense for Manufacturing of Monoclonal Antibodies (Investegate)
19.01.21
Evotec SE : Preliminary announcement of the publication of quarterly reports and quarterly/interim statements (Investegate)
19.01.21
Evotec SE : Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] (Investegate)
07.01.21
Evotec SE : EVOTEC TO ATTEND UPCOMING INVESTOR CONFERENCES (Investegate)
05.01.21
Evotec SE : EVOTEC ACHIEVES MILESTONE IN ITS NEURODEGENERATION COLLABORATION WITH BRISTOL MYERS SQUIBB (Investegate)
04.01.21
Evotec SE : Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (Investegate)
30.12.20
Evotec SE : Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (Investegate)
21.12.20
Evotec SE : EVOTEC PARTNERS WITH ALLOY THERAPEUTICS TO EXPAND ITS ANTIBODY DISCOVERY PLATFORM (Investegate)
17.12.20
Evotec SE : EVOTEC ACHIEVES KEY MILESTONES IN ITS COLLABORATION WITH BRISTOL MYERS SQUIBB ON TARGETED PROTEIN DEGRADATION (Investegate)
30.11.20
Evotec SE : Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (Investegate)
24.11.20
Evotec SE : EVOTEC AND RAPPTA THERAPEUTICS ENTER DISCOVERY AND DEVELOPMENT PARTNERSHIP FOCUSED ON ONCOLOGY TARGET (Investegate)
20.11.20
Evotec SE : Correction of a release from 27/10/2020 according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (Investegate)
19.11.20
Evotec SE : EVOTEC PRESENTS GROWTH DRIVERS OF 'AUTOBAHN TO CURES' AT CAPITAL MARKETS DAY (Investegate)
17.11.20
Evotec SE : EVOTEC AND STORM THERAPEUTICS LEVERAGE INDIGO PLATFORM TO PROGRESS ONCOLOGY PROJECT TOWARDS CLINICAL STUDIES (Investegate)
12.11.20
Evotec SE : EVOTEC EXPANDS OXFORDSHIRE SITE INTO A FULLY-INTEGRATED R&D CENTRE NAMED 'DOROTHY CROWFOOT HODGKIN CAMPUS' (Investegate)
12.11.20
Evotec SE : EVOTEC SE REPORTS RESULTS FOR THE FIRST NINE MONTHS 2020 AND PROVIDES CORPORATE UPDATE (Investegate)
Seite: 123456789

EVOTEC News

EVOTEC News: auf dieser Seite finden Sie alle EVOTEC News und Nachrichten zur EVOTEC Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch EVOTEC News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um EVOTEC News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.
Werbung
finanzen.net Brokerage
finanzen.net Zero

Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln